About the Webinar
Watch our exclusive webinar to see how cutting-edge AI is transforming screening and ligand identification in drug discovery!
In this webinar, our expert speakers, Benedikt Bauer PhD (Group Leader, In Silico R&D) and Ghislaine Marchand PhD (Group Leader, Biophysics), explore AI/ML technologies and how they have been applied during hit discovery to reduce cost, enhance speed and decrease risk.
Key Insights
- Understand how AI/ML technologies are integrated into ASMS workflows
- Evaluate the impact of AI/ML-driven enrichment on screening efficiency
- Gain knowledge of real-world application of AI/ML in hit discovery
Meet the Speakers:
If the webinar has not loaded above, please click the link here.